Filter your results
- 4
- 2
- 4
- 2
- 1
- 6
- 1
- 1
- 3
- 2
- 1
- 6
- 3
- 3
- 1
- 1
- 1
- 1
- 1
- 6
- 5
- 4
- 4
- 3
- 3
- 3
- 3
- 3
- 3
- 3
- 3
- 3
- 3
- 3
- 2
- 2
- 2
- 2
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
|
|
sorted by
|
|
H3K27me3 is a determinant of chemotolerance in triple-negative breast cancer2021
Preprints, Working Papers, ...
hal-03140117v1
|
||
|
To portray clonal evolution in blood cancer, count your stem cellsBlood, 2020, ⟨10.1182/blood.2020008407⟩
Journal articles
hal-03097640v1
|
||
|
Erythropoietin directly remodels the clonal composition of murine hematopoietic multipotent progenitor cellseLife, 2022, 11, ⟨10.7554/elife.66922⟩
Journal articles
hal-03674296v1
|
||
|
H3K27me3 conditions chemotolerance in triple-negative breast cancerNature Genetics, 2022, 54, pp.459-468. ⟨10.1038/s41588-022-01047-6⟩
Journal articles
hal-03851953v1
|
||
|
Inhibition of the pseudokinase MLKL alters extracellular vesicle release and reduces tumor growth in glioblastomaiScience, 2022, ⟨10.1016/j.isci⟩
Journal articles
hal-03874619v1
|
||
|
H3K27me3 is a determinant of chemotolerance in triple-negative breast cancer2021
Preprints, Working Papers, ...
hal-03417195v1
|